A Digital Publication for the Practicing Medical Specialist, Industry Executive and Investor

Medical Device News Magazine is committed to delivering high‑quality, in‑depth medical device news and biotechnology updates that include expert bylines. Our coverage offers a comprehensive view of the trends, innovations, and breakthroughs shaping the future of medical technology.

We also strive to provide a distinctive perspective on the rapidly evolving healthcare landscape. By staying connected with our reporting, you gain access to exclusive insights on industry developments, emerging technologies, and global regulatory changes that influence the medical device sector. At the same time, you join a vibrant community of professionals, innovators, and thought leaders dedicated to advancing healthcare through cutting‑edge solutions.

We invite you to explore our wide range of content—from the latest product announcements to detailed analyses of industry trends. And if our mission aligns with your goals, we offer opportunities for advertising and collaboration, helping you connect with a highly engaged audience of medical technology professionals.

Definition medical devices.

Medical Device Industry News | Latest Developments, Breakthroughs & Future Outlook

Latest News and Developments

Ellipsys Vascular Access System to Return to U.S. Market in 2026

Ellipsys Vascular Access System to Return to U.S. Market in 2026

Ellipsys Medical, Inc. today announced that the Ellipsys® Vascular Access System will once again be commercially available, with initial availability anticipated in mid-2026. The announcement marks the planned reintroduction of the minimally invasive technology to clinicians and patients following a period of limited market availability. The Ellipsys System, previously available...

Clinical Trials

Biotechnology News

Mergers & Acquisitions

Funding

Instylla Announces Completion of $30MM EQUITY Financing

As part of this round of financing, Henry Chen, Managing Partner, Delos Capital has joined the Instylla Board of Directors. “Instylla has demonstrated impressive progress, having already advanced its next-generation liquid embolic technology to human clinical studies. We are honored and thrilled to support Instylla as it continues developing breakthrough solutions that will meaningfully improve patient outcomes,” said Henry Chen.

Persist AI Raises $4M in Seed Financing, Rapidly Accelerates Drug Formulation

Over the past 6 months, Persist AI has developed cutting- edge robotics that enables automated development of long-acting injectable formulations. Coupled with AI models, they are able to rapidly predict which formulations will release drugs in the body for a long time and reduce the number of injections that patients need.

Industry Expert Bylines

Proactively Building in Efficiency in Machine Translation Engines to Reduce Our Carbon Footprint

Proactively Building in Efficiency in Machine Translation Engines to Reduce Our Carbon Footprint

Dan Milczarski writes, “Recent estimates suggest that the carbon footprint of training a single AI is as much as 284 tons of carbon dioxide equivalent — five times the lifetime emissions of an average car. As a responsible global citizen, organizations and corporations should feel ethically compelled to do their part to improve our earth’s prognosis in this time of climate change.” Read on to learn more!

FDA Medical Device Updates

Market Reports

Executives

Advancements In Imaging

Hospitals In the News

Non-Profit News

Healthcare: Understanding the Business Side of the Industry and Its Implications

How to Generate More Patient Leads in 2023

How to Generate More Patient Leads in 2023

Introduction Are you looking for ways to generate more patient leads in 2023? The healthcare industry is becoming increasingly competitive and it can be difficult

Healthcare Careers

Nurses Corner

Health: A Comprehensive Exploration of Wellness, Nutrition, and Overall Well-Being for a Healthier Life

Articles Designed to Inspire and Guide You Toward Achieving Excellence and Success in All Your Endeavors.